This search lists information on applications for centralised marketing authorisations for human medicines that are under evaluation by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).
The list of medicines under evaluation is updated each month. It includes the international non-proprietary names (INN) and therapeutic areas for all new innovative medicines under evaluation by the CHMP. For generic and biosimilar medicines, it includes the INN (active moiety only, with no information on salt, ester or derivative) and therapeutic area.
Lsits of medicines under evaluation can be downloaded in PDF format.
- Landing Page
- Release Date
- Modified Date
- Accrual Periodicity
- Geographical Coverage
- Romania, Slovakia, Slovenia, Sweden, Malta, Netherlands, Poland, Portugal, Belgium, Austria, Cyprus, Bulgaria, Germany, Czechia, Spain, Denmark, Finland, Estonia, United Kingdom, France, Croatia, Greece, Ireland, Hungary, Lithuania, Italy, Latvia, Luxembourg
- European Union Open Data Portal
European Medicines Agency